|
1
|
Lunet N, Valbuena C, Vieira AL, Lopes C,
Lopes C, David L, Carneiro F and Barros H: Fruit and vegetable
consumption and gastric cancer by location and histological type:
Case-control and meta-analysis. Eur J Cancer Prev. 16:312–327.
2007.
|
|
2
|
Ladeiras-Lopes R, Pereira AK, Nogueira A,
Pinheiro-Torres T, Pinto I, Santos-Pereira R and Lunet N: Smoking
and gastric cancer: Systematic review and meta-analysis of cohort
studies. Cancer Causes Control. 19:689–701. 2008.
|
|
3
|
Yang P, Zhou Y, Chen B, Wan HW, Jia GQ,
Bai HL and Wu XT: Overweight, obesity and gastric cancer risk:
Results from a meta-analysis of cohort studies. Eur J Cancer.
45:2867–2873. 2009.
|
|
4
|
Bornschein J, Selgrad M, Warnecke M,
Kuester D, Wex T and Malfertheiner P: H. pylori infection is
a key risk factor for proximal gastric cancer. Dig Dis Sci.
55:3124–3131. 2010.
|
|
5
|
Wu MS, Shun CT, Wu CC, Hsu TY, Lin MT,
Chang MC, Wang HP and Lin JT: Epstein-Barr virus-associated gastric
carcinomas: Relation to H. pylori infection and genetic
alterations. Gastroenterology. 118:1031–1038. 2000.
|
|
6
|
Wang HH, Wu MS, Shun CT, Wang HP, Lin CC
and Lin JT: Lymphoepithelioma-like carcinoma of the stomach: A
subset of gastric carcinoma with distinct clinicopathological
features and high prevalence of Epstein-Barr virus infection.
Hepatogastroenterology. 46:1214–1219. 1999.
|
|
7
|
Oliveira C, Pinheiro H, Figueiredo J,
Seruca R and Carneiro F: Familial gastric cancer genetic
susceptibility, pathology, and implications for management. Lancet
Oncol. 16:e60–e70. 2015.
|
|
8
|
Van Cutsem E, Sagaert X, Topal B,
Haustermans K and Prenen H: Gastric cancer. Lancet. 388:2654–2664.
2016.
|
|
9
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. dv Exp Med Biol. 774:1–20. 2013.
|
|
10
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531.
2004.
|
|
11
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009.
|
|
12
|
Shi Y, Wang Z, Zhu X, Chen L, Ma Y, Wang
J, Yang X and Liu Z: Exosomal miR-1246 in serum as a potential
biomarker for early diagnosis of gastric cancer. Int J Clin Oncol.
25:89–99. 2020.
|
|
13
|
Ishikawa D, Yoshikawa K, Takasu C,
Kashihara H, Nishi M, Tokunaga T, Higashijima J and Shimada M:
Expression level of MicroRNA-449a predicts the prognosis of
patients with gastric cancer. Anticancer Res. 40:239–244. 2020.
|
|
14
|
Chen P, Guo H, Wu X, Li J, Duan X, Ba Q
and Wang H: Epigenetic silencing of microRNA-204 by Helicobacter
pylori augments the NF-κB signaling pathway in gastric cancer
development and progression. Carcinogenesis. 41:430–441. 2020.
|
|
15
|
Garzon R, Marcucci G and Croce CM:
Targeting microRNAs in cancer: Rationale, strategies and
challenges. Nat Rev Drug Discov. 9:775–789. 2010.
|
|
16
|
Sun X, Hou H, Li K and Zheng M:
microRNA-761 regulates glycogen synthase kinase 3β expression and
promotes the proliferation and cell cycle of human gastric cancer
cells. Oncol Lett. 16:3459–3464. 2018.
|
|
17
|
Liu Z, Yu M, Fei B, Fang X, Ma T and Wang
D: miR-21-5p targets PDHA1 to regulate glycolysis and cancer
progression in gastric cancer. Oncol Rep. 40:2955–2963. 2018.
|
|
18
|
Jiang Y, Zhang M, Guo T, Yang C, Zhang C
and Hao J: MicroRNA-21-5p promotes proliferation of gastric cancer
cells through targeting SMAD7. Onco Targets Ther. 11:4901–4911.
2018.
|
|
19
|
Hua K, Chen YT, Chen CF, Tang YS, Huang
TT, Lin YC, Yeh TS, Huang KH, Lee HC, Hsu MT, et al:
MicroRNA-23a/27a/24-2 cluster promotes gastric cancer cell
proliferation synergistically. Oncol Lett. 16:2319–2325. 2018.
|
|
20
|
Sherr CJ: Principles of tumor suppression.
Cell. 116:235–246. 2004.
|
|
21
|
Vogelstein B, Lane D and Levine AJ:
Surfing the p53 network. Nature. 408:307–310. 2000.
|
|
22
|
Wang J, Zheng X, Qin Z, Wei L, Lu Y, Peng
Q, Gao Y, Zhang X, Zhang X, Li Z, et al: Epstein-Barr virus
miR-BART3-3p promotes tumorigenesis by regulating the senescence
pathway in gastric cancer. J Biol Chem. 294:4854–4866. 2019.
|
|
23
|
Xu LF, Wu ZP, Chen Y, Zhu QS, Hamidi S and
Navab R: MicroRNA-21 (miR-21) regulates cellular proliferation,
invasion, migration, and apoptosis by targeting PTEN, RECK and
Bcl-2 in lung squamous carcinoma, Gejiu City, China. PLoS
One. 9:e1036982014.
|
|
24
|
Chen X, Wang W, Zhang J, Li S, Zhao Y, Tan
L and Luo A: Involvement of caspase-3/PTEN signaling pathway in
isoflurane-induced decrease of self-renewal capacity of hippocampal
neural precursor cells. Brain Res. 1625:275–286. 2015.
|
|
25
|
Yao L, Shi W and Gu J: Micro-RNA 205-5p is
involved in the progression of gastric cancer and targets
phosphatase and tensin homolog (PTEN) in SGC-7901 human gastric
cancer cells. Med Sci Monit. 25:6367–6377. 2019.
|
|
26
|
Fan H, Jin X, Liao C, Qiao L and Zhao W:
MicroRNA-301b-3p accelerates the growth of gastric cancer cells by
targeting zinc finger and BTB domain containing 4. Pathol Res
Pract. 215:1526672019.
|
|
27
|
Yang X, Wang M, Lin B, Yao D, Li J, Tang
X, Li S, Liu Y, Xie R and Yu S: miR-487a promotes progression of
gastric cancer by targeting TIA1. Biochimie. 154:119–126. 2018.
|
|
28
|
Yu J, Qi J, Sun X, Wang W, Wei G, Wu Y,
Gao Q and Zheng J: MicroRNA-181a promotes cell proliferation and
inhibits apoptosis in gastric cancer by targeting RASSF1A. Oncol
Rep. 40:1959–1970. 2018.
|
|
29
|
Li S, Liang X, Ma L, Shen L, Li T, Zheng
L, Sun A, Shang W, Chen C, Zhao W and Jia J: miR-22 sustains NLRP3
expression and attenuates H. pylori-induced gastric
carcinogenesis. Oncogene. 37:884–896. 2018.
|
|
30
|
Takaishi S, Okumura T and Wang TC: Gastric
cancer stem cells. J Clin Oncol. 26:2876–2882. 2008.
|
|
31
|
Ezeh UI, Turek PJ, Reijo RA and Clark AT:
Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are
expressed in both seminoma and breast carcinoma. Cancer.
104:2255–2265. 2005.
|
|
32
|
Song H, Shi L, Xu Y, Xu T, Fan R, Cao M,
Xu W and Song J: BRD4 promotes the stemness of gastric cancer cells
via attenuating miR-216a-3p-mediated inhibition of Wnt/β-catenin
signaling. Eur J Pharmacol. 852:189–197. 2019.
|
|
33
|
Lin H, Zhou AJ, Zhang JY, Liu SF and Gu
JX: miR-324-5p reduces viability and induces apoptosis in gastric
cancer cells through modulating TSPAN8. J Pharm Pharmacol.
70:1513–1520. 2018.
|
|
34
|
Li S, Zhang T, Zhou X, Du Z, Chen F, Luo J
and Liu Q: The tumor suppressor role of miR-155-5p in gastric
cancer. Oncol Lett. 16:2709–2714. 2018.
|
|
35
|
Zhang X, Zhang M, Guo Q, Hu X, Zhao Z, Ni
L, Liu L, Wang X, Wang Z, Tong D, et al: MicroRNA-1297 inhibits
proliferation and promotes apoptosis in gastric cancer cells by
downregulating CDC6 expression. Anticancer Drugs. 30:803–811.
2019.
|
|
36
|
Chen W, Cui Y, Wang J, Yuan Y, Sun X,
Zhang L, Shen S and Cheng J: Effects of downregulated expression of
microRNA-187 in gastric cancer. Exp Ther Med. 16:1061–1070.
2018.
|
|
37
|
Shi Y, Lee JS and Galvin KM: Everything
you have ever wanted to know about Yin Yang 1. Biochim Biophys
Acta. 1332:F49–F66. 1997.
|
|
38
|
Sui G, Affar el B and Shi Y, Brignone C,
Wall NR, Yin P, Donohoe M, Luke MP, Calvo D, Grossman SR and Shi Y:
Yin Yang 1 is a negative regulator of p53. Cell. 117:859–872.
2004.
|
|
39
|
Wu S, Kasim V, Kano MR, Tanaka S, Ohba S,
Miura Y, Miyata K, Liu X, Matsuhashi A, Chung UI, et al:
Transcription factor YY1 contributes to tumor growth by stabilizing
hypoxia factor HIF-1α in a p53-independent manner. Cancer Res.
73:1787–1799. 2013.
|
|
40
|
Zhou GQ, Han F, Shi ZL, Yu L, Li XF, Yu C,
Shen CL, Wan DW, Zhu XG, Li R and He SB: DNMT3A-mediated
down-regulation of microRNA-105 promotes gastric cancer cell
proliferation. Eur Rev Med Pharmacol Sci. 21:3377–3383. 2017.
|
|
41
|
Xu G, Li N, Zhang Y, Zhang J, Xu R and Wu
Y: MicroRNA-383-5p inhibits the progression of gastric carcinoma
via targeting HDAC9 expression. Braz J Med Biol Res.
52:e83412019.
|
|
42
|
Ooms LM, Binge LC, Davies EM, Rahman P,
Conway JR, Gurung R, Ferguson DT, Papa A, Fedele CG, Vieusseux JL,
et al: The inositol polyphosphate 5-phosphatase PIPP regulates
AKT1-dependent breast cancer growth and metastasis. Cancer Cell.
28:155–169. 2015.
|
|
43
|
Sahlberg SH, Spiegelberg D, Glimelius B,
Stenerlöw B and Nestor M: Evaluation of cancer stem cell markers
CD133, CD44, CD24: Association with AKT isoforms and radiation
resistance in colon cancer cells. PLoS One. 9:e946212014.
|
|
44
|
Etemadmoghadam D and Bowtell D: AKT1 gene
amplification as a biomarker of treatment response in ovarian
cancer: Mounting evidence of a therapeutic target. Gynecol Oncol.
135:409–410. 2014.
|
|
45
|
Yu H, Sun J, Jiang S and Xu Y:
MicroRNA-490-3p regulates cell proliferation and apoptosis in
gastric cancer via direct targeting of AKT1. Exp Ther Med.
17:1330–1336. 2019.
|
|
46
|
Liu F, Hu H, Zhao J, Zhang Z, Ai X, Tang L
and Xie L: miR-124-3p acts as a potential marker and suppresses
tumor growth in gastric cancer. Biomed Rep. 9:147–155. 2018.
|
|
47
|
Zhu CY, Meng FQ and Liu J: MicroRNA-524-5p
suppresses cell proliferation and promotes cell apoptosis in
gastric cancer by regulating CASP3. Eur Rev Med Pharmacol Sci.
23:7968–7977. 2019.
|
|
48
|
Zhao M, Liu Q, Liu W, Zhou H, Zang X and
Lu J: MicroRNA-140 suppresses Helicobacter pylori-positive
gastric cancer growth by enhancing the antitumor immune response.
Mol Med Rep. 20:2484–2492. 2019.
|
|
49
|
Geng Y, Lu X, Wu X, Xue L, Wang X and Xu
J: MicroRNA-27b suppresses Helicobacter pylori-induced
gastric tumorigenesis through negatively regulating Frizzled7.
Oncol Rep. 35:2441–2450. 2016.
|
|
50
|
Zhou X, Xia Y, Li L and Zhang G: miR-101
inhibits cell growth and tumorigenesis of Helicobacter
pylori related gastric cancer by repression of SOCS2. Cancer
Biol Ther. 16:160–169. 2015.
|
|
51
|
Feng Y, Wang L, Zeng J, Shen L, Liang X,
Yu H, Liu S, Liu Z, Sun Y, Li W, et al: FoxM1 is overexpressed in
Helicobacter pylori-induced gastric carcinogenesis and is
negatively regulated by miR-370. Mol Cancer Res. 11:834–844.
2013.
|
|
52
|
Yang L, Li C and Jia Y: MicroRNA-99b
promotes Helicobacter pylori-induced autophagyand suppresses
carcinogenesis by targeting mTOR. Oncol Lett. 16:5355–5360.
2018.
|
|
53
|
Liu S, Tian Y, Zhu C, Yang X and Sun Q:
High miR-718 suppresses phosphatase and tensin homolog (PTEN)
expression and correlates to unfavorable prognosis in gastric
cancer. Med Sci Monit. 24:5840–5850. 2018.
|
|
54
|
Wang Q, He Y, Kan W, Li F, Ji X, Wu X,
Wang X, Zhang Y and Chen J: microRNA-32-5p targets KLF2 to promote
gastric cancer by activating PI3K/AKT signaling pathway. Am J
Transl Res. 11:4895–4908. 2019.
|
|
55
|
Zhou H, Liu H, Jiang M, Zhang S, Chen J
and Fan X: Targeting MicroRNA-21 suppresses gastric cancer cell
proliferation and migration via PTEN/Akt signaling axis. Cell
Transplant. 28:306–317. 2019.
|
|
56
|
Wei S, Peng L, Yang J, Sang H, Jin D, Li
X, Chen M, Zhang W, Dang Y and Zhang G: Exosomal transfer of
miR-15b-3p enhances tumorigenesis and malignant transformation
through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric
cancer. J Exp Clin Cancer Res. 39:322020.
|
|
57
|
Huang J, Shen M, Yan M, Cui Y, Gao Z and
Meng X: Exosome-mediated transfer of miR-1290 promotes cell
proliferation and invasion in gastric cancer via NKD1. Acta Biochim
Biophys Sin (Shanghai). 51:900–907. 2019.
|
|
58
|
Angonin D and Van Raay TJ: Nkd1 functions
as a passive antagonist of Wnt signaling. PLoS One.
8:e746662013.
|
|
59
|
Yan D, Wallingford JB, Sun TQ, Nelson AM,
Sakanaka C, Reinhard C, Harland RM, Fantl WJ and Williams LT: Cell
autonomous regulation of multiple dishevelled-dependent pathways by
mammalian Nkd. Proc Natl Acad Sci USA. 98:3802–3807. 2001.
|
|
60
|
Wharton KA Jr, Zimmermann G, Rousset R and
Scott MP: Vertebrate proteins related to drosophila naked cuticle
bind dishevelled and antagonize Wnt signaling. Dev Biol.
234:93–106. 2001.
|
|
61
|
Zhu Y, Jiang Q, Lou X, Ji X, Wen Z, Wu J,
Tao H, Jiang T, He W, Wang C, et al: MicroRNAs up-regulated by CagA
of Helicobacter pylori induce intestinal metaplasia of
gastric epithelial cells. PLoS One. 7:e351472012.
|
|
62
|
Shen E, Wang X, Liu X, Lv M, Zhang L, Zhu
G and Sun Z: MicroRNA-93-5p promotes epithelial-mesenchymal
transition in gastric cancer by repressing tumor suppressor AHNAK
expression. Cancer Cell Int. 20:762020.
|
|
63
|
Nagl NG Jr, Patsialou A, Haines DS, Dallas
PB, Beck GR Jr and Moran E: The p270 (ARID1A/SMARCF1) subunit of
mammalian SWI/SNF-related complexes is essential for normal cell
cycle arrest. Cancer Res. 65:9236–9244. 2005.
|
|
64
|
Shigetomi H, Oonogi A, Tsunemi T, Tanase
Y, Yamada Y, Kajihara H, Yoshizawa Y, Furukawa N, Haruta S, Yoshida
S, et al: The role of components of the chromatin modification
machinery in carcinogenesis of clear cell carcinoma of the ovary
(Review). Oncol Lett. 2:591–597. 2011.
|
|
65
|
Cheng S, Wang L, Deng CH, Du SC and Han
ZG: ARID1A represses hepatocellular carcinoma cell proliferation
and migration through lncRNA MVIH. Biochem Biophys Res Commun.
491:178–182. 2017.
|
|
66
|
Zhu Y, Li K, Yan L, He Y, Wang L and Sheng
L: miR-223-3p promotes cell proliferation and invasion by targeting
Arid1a in gastric cancer. Acta Biochim Biophys Sin (Shanghai).
52:150–159. 2020.
|
|
67
|
Yang Y, Yin ZX, Wang ZY, Tian SB, Wang HC,
Zhang FX, Li LP, Zheng C and Kong S: miR-7641 depletion suppresses
proliferation of gastric cancer cells by targeting ARID1A.
Anticancer Drugs. 31:368–376. 2020.
|
|
68
|
Zhang X, Zhang M, Wang G, Tian Y and He X:
Tumor promoter role of miR-647 in gastric cancer via repression of
TP73. Mol Med Rep. 18:3744–3750. 2018.
|
|
69
|
Yang F, Xu Y, Liu C, Ma C, Zou S, Xu X,
Jia J and Liu Z: NF-κB/miR-223-3p/ARID1A axis is involved in
Helicobacter pylori CagA-induced gastric carcinogenesis and
progression. Cell Death Dis. 9:122018.
|
|
70
|
Cui HB, Ge HE, Wang YS and Bai XY:
miR-208a enhances cell proliferation and invasion of gastric cancer
by targeting SFRP1 and negatively regulating MEG3. Int J Biochem
Cell Biol. 102:31–39. 2018.
|
|
71
|
Lin J, Shen J, Yue H and Cao Z:
miRNA-183-5p.1 promotes the migration and invasion of gastric
cancer AGS cells by targeting TPM1. Oncol Rep. 42:2371–2381.
2019.
|
|
72
|
Pelengaris S and Khan M: The many faces of
c-MYC. Arch Biochem Biophys. 416:129–136. 2003.
|
|
73
|
Deng T, Zhang H, Yang H, Wang H, Bai M,
Sun W, Wang X, Si Y, Ning T, Zhang L, et al: Exosome miR-155
derived from gastric carcinoma promotes angiogenesis by targeting
the c-MYB/VEGF axis of endothelial cells. Mol Ther Nucleic Acids.
19:1449–1459. 2020.
|
|
74
|
Maiese K, Hou J, Chong ZZ and Shang YC: A
fork in the path: Developing therapeutic inroads with FoxO
proteins. Oxid Med Cell Longev. 2:119–129. 2009.
|
|
75
|
Zhou Z, Zhang H, Deng T, Ning T, Liu R,
Liu D, Bai M, Ying G and Ba Y: Exosomes carrying MicroRNA-155
target forkhead box O3 of endothelial cells and promote
angiogenesis in gastric cancer. Mol Ther Oncolytics. 15:223–233.
2019.
|
|
76
|
Yang H, Zhang H, Ge S, Ning T, Bai M, Li
J, Li S, Sun W, Deng T, Zhang L, et al: Exosome-derived miR-130a
activates angiogenesis in gastric cancer by targeting C-MYB in
vascular endothelial cells. Mol Ther. 26:2466–2475. 2018.
|
|
77
|
Shi Y, Yang Z, Zhang T, Shen L, Li Y and
Ding S: SIRT1-targeted miR-543 autophagy inhibition and
epithelial-mesenchymal transition promotion in Helicobacter
pylori CagA-associated gastric cancer. Cell Death Dis.
10:6252019.
|
|
78
|
Tan X, Tang H, Bi J, Li N and Jia Y:
MicroRNA-222-3p associated with Helicobacter pylori targets
HIPK2 to promote cell proliferation, invasion, and inhibits
apoptosis in gastric cancer. J Cell Biochem. 119:5153–5162.
2018.
|
|
79
|
Cheng Y, Jia B, Wang Y and Wan S: miR-133b
acts as a tumor suppressor and negatively regulates ATP citrate
lyase via PPARγ in gastric cancer. Oncol Rep. 38:3220–3226.
2017.
|
|
80
|
Cai H, Lin H, Cao W, Sun J, Huang Y and
Fang Y: Downregulation of miR-519a predicts poor prognosis and
contributes to tumor progression in gastric cancer. Oncol Res
Treat. 43:19–26. 2020.
|
|
81
|
Lv H, Hou H, Lei H, Nie C, Chen B, Bie L,
Han L and Chen X: MicroRNA-6884-5p regulates the proliferation,
invasion and EMT of gastric cancer cells by directly targeting
S100A16. Oncol Res. 28:225–236. 2020.
|
|
82
|
Chen XB, Li W and Chu AX: MicroRNA-133a
inhibits gastric cancer cells growth, migration, and
epithelial-mesenchymal transition process by targeting presenilin
1. J Cell Biochem. 120:470–480. 2019.
|
|
83
|
Yu H, Zhang J, Wen Q, Dai Y, Zhang W, Li F
and Li J: MicroRNA-6852 suppresses cell proliferation and invasion
via targeting forkhead box J1 in gastric cancer. Exp Ther Med.
16:3249–3255. 2018.
|
|
84
|
Ouyang Y, Yuan W and Qiu S: MicroRNA-153
functions as a tumor suppressor in gastric cancer via targeting
Kruppel-like factor 5. Exp Ther Med. 16:473–482. 2018.
|
|
85
|
Jia C, Zhang Y, Xie Y, Ren Y, Zhang H,
Zhou Y, Gao N, Ding S and Han S: miR-200a-3p plays tumor suppressor
roles in gastric cancer cells by targeting KLF12. Artif Cells
Nanomed Biotechnol. 47:3697–3703. 2019.
|
|
86
|
Su H, Ren F, Jiang H, Chen Y and Fan X:
Upregulation of microRNA-520a-3p inhibits the proliferation,
migration and invasion via spindle and kinetochore associated 2 in
gastric cancer. Oncol Lett. 18:3323–3330. 2019.
|
|
87
|
Song Z, Li W, Wang L, Jia N and Chen B:
MicroRNA-454 inhibits tumor cell proliferation, migration and
invasion by downregulating zinc finger E-box-binding homeobox 1 in
gastric cancer. Mol Med Rep. 16:9067–9073. 2017.
|
|
88
|
Zhang J, Wang C, Yan S, Yang Y, Zhang X
and Guo W: miR-345 inhibits migration and stem-like cell phenotype
in gastric cancer via inactivation of Rac1 by targeting EPS8. Acta
Biochim Biophys Sin (Shanghai). 52:259–267. 2020.
|
|
89
|
Wang J, Feng W, Dong Y, Mao X, Guo F and
Luo F: MicroRNA-495 regulates human gastric cancer cell apoptosis
and migration through Akt and mTOR signaling. Oncol Rep.
40:3654–3662. 2018.
|
|
90
|
Yuan KT, Li BX, Yuan YJ, Tan M, Tan JF,
Dai WG, Feng WD and Zuo JD: Deregulation of MicroRNA-375 inhibits
proliferation and migration in gastric cancer in association with
autophagy-mediated AKT/mTOR signaling pathways. Technol Cancer Res
Treat. 17:15330338188064992018.
|
|
91
|
Miao L, Liu K, Xie M, Xing Y and Xi T:
miR-375 inhibits Helicobacter pylori-induced gastric
carcinogenesis by blocking JAK2-STAT3 signaling. Cancer Immunol
Immunother. 63:699–711. 2014.
|
|
92
|
Xu XC, Zhang WB, Li CX, Gao H, Pei Q, Cao
BW and He TH: Up-regulation of miR-1915 inhibits proliferation,
invasion, and migration of Helicobacter pylori-infected
gastric cancer cells via targeting RAGE. Yonsei Med J. 60:38–47.
2019.
|
|
93
|
Zhang S, Zhang R, Xu R, Shang J, He H and
Yang Q: MicroRNA-574-5p in gastric cancer cells promotes
angiogenesis by targeting protein tyrosine phosphatase non-receptor
type 3 (PTPN3). Gene. 733:1443832020.
|
|
94
|
Li Q, Li B, Li Q, Wei S, He Z, Huang X,
Wang L, Xia Y, Xu Z, Li Z, et al: Exosomal miR-21-5p derived from
gastric cancer promotes peritoneal metastasis via
mesothelial-to-mesenchymal transition. Cell Death Dis.
9:8542018.
|
|
95
|
Feng C, She J, Chen X, Zhang Q, Zhang X,
Wang Y, Ye J, Shi J, Tao J, Feng M, et al: Exosomal miR-196a-1
promotes gastric cancer cell invasion and metastasis by targeting
SFRP1. Nanomedicine (Lond). 14:2579–2593. 2019.
|
|
96
|
Zhang X, Peng Y, Huang Y, Deng S, Feng X,
Hou G, Lin H, Wang J, Yan R, Zhao Y, et al: Inhibition of the
miR-192/215-Rab11-FIP2 axis suppresses human gastric cancer
progression. Cell Death Dis. 9:7782018.
|
|
97
|
Sun F, Ni Y, Zhu H, Fang J, Wang H, Xia J,
Ding F, Shen H and Shao S: microRNA-29a-3p, Up-regulated in human
gastric cells and tissues with H. Pylori infection, promotes
the migration of GES-1 cells via A20-mediated EMT pathway. Cell
Physiol Biochem. 51:1250–1263. 2018.
|
|
98
|
Zhang Q, Sui Y and Sui X: MicroRNA-761
inhibits the metastasis of gastric cancer by negatively regulating
Ras and Rab interactor 1. Oncol Lett. 18:3097–3103. 2019.
|
|
99
|
Xiao F, Cheng Z, Wang P, Gong B, Huang H,
Xing Y and Liu F: MicroRNA-28-5p inhibits the migration and
invasion of gastric cancer cells by suppressing AKT
phosphorylation. Oncol Lett. 15:9777–9785. 2018.
|
|
100
|
Bassères DS, Tizzei EV, Duarte AA, Costa
FF and Saad ST: ARHGAP10, a novel human gene coding for a
potentially cytoskeletal Rho-GTPase activating protein. Biochem
Biophys Res Commun. 294:579–585. 2002.
|
|
101
|
Wang Z, Yao L, Li Y, Hao B, Wang M, Wang
J, Gu W, Zhan H, Liu G and Wu Q: miR-337-3p inhibits gastric tumor
metastasis by targeting ARHGAP10. Mol Med Rep. 21:705–719.
2020.
|
|
102
|
Clem BF, O'Neal J, Tapolsky G, Clem AL,
Imbert-Fernandez Y, Kerr DA II, Klarer AC, Redman R, Miller DM,
Trent JO, et al: Targeting 6-phosphofructo-2-kinase (PFKFB3) as a
therapeutic strategy against cancer. Mol Cancer Ther. 12:1461–1470.
2013.
|
|
103
|
Imbert-Fernandez Y, Clem A, Clem B,
Tapolsky G, Telang S and Chesney J: Suppression of
6-phosphofructo-2-kinase (PFKFB3) for the treatment of breast
cancer. Cancer Res. 76(14 Suppl): S562016.
|
|
104
|
Chen X, Wang A and Yue X: miR-449c
inhibits migration and invasion of gastric cancer cells by
targeting PFKFB3. Oncol Lett. 16:417–424. 2018.
|
|
105
|
Xiao WS, Li DF, Tang YP, Chen YZ, Deng WB,
Chen J, Zhou WW and Liao AJ: Inhibition of epithelial-mesenchymal
transition in gastric cancer cells by miR-711-mediated down-
regulation of CD44 expression. Oncol Rep. 40:2844–2853. 2018.
|
|
106
|
Li J, Zhang B, Cui J, Liang Z and Liu K:
miR-203 inhibits the invasion and EMT of gastric cancer cells by
directly targeting annexin A4. Oncol Res. 27:789–799. 2019.
|
|
107
|
Zhou X, Xu G, Yin C, Jin W and Zhang G:
Down-regulation of miR-203 induced by Helicobacter pylori
infection promotes the proliferation and invasion of gastric cancer
by targeting CASK. Oncotarget. 5:11631–11640. 2014.
|
|
108
|
Chen G, Yang Z, Feng M and Wang Z:
microRNA-217 suppressed epithelial-to-mesenchymal transition
through targeting PTPN14 in gastric cancer. Biosci Rep.
40:BSR201931762020.
|
|
109
|
Zhang M, Huang S and Long D: miR-381
inhibits migration and invasion in human gastric carcinoma through
downregulatedting SOX4. Oncol Lett. 14:3760–3766. 2017.
|
|
110
|
Wang F, Liu J, Zou Y, Jiao Y, Huang Y, Fan
L, Li X, Yu H, He C, Wei W, et al: MicroRNA-143-3p, up-regulated in
H. pylori-positive gastric cancer, suppresses tumor growth,
migration and invasion by directly targeting AKT2. Oncotarget.
8:28711–28724. 2017.
|
|
111
|
Liu X, Ji Q, Zhang C, Liu X, Liu Y, Liu N,
Sui H, Zhou L, Wang S and Li Q: miR-30a acts as a tumor suppressor
by double-targeting COX-2 and BCL9 in H. pylori gastric
cancer models. Sci Rep. 7:71132017.
|
|
112
|
Emami SS, Nekouian R, Akbari A, Faraji A,
Abbasi V and Agah S: Evaluation of circulating miR-21 and miR-222
as diagnostic biomarkers for gastric cancer. J Cancer Res Ther.
15:115–119. 2019.
|
|
113
|
Saito R, Maruyama S, Kawaguchi Y, Akaike
H, Shimizu H, Furuya S, Kawaida H and Ichikawa D: miR-99a-5p as
possible diagnostic and prognostic marker in patients with gastric
cancer. J Surg Res. 250:193–199. 2020.
|
|
114
|
ZiaSarabi P, Sorayayi S, Hesari A and
Ghasemi F: Circulating microRNA-133, microRNA-17 and microRNA-25 in
serum and its potential diagnostic value in gastric cancer. J Cell
Biochem. 120:12376–12381. 2019.
|
|
115
|
Ji B, Huang Y, Gu T, Zhang L, Li G and
Zhang C: Potential diagnostic and prognostic value of plasma long
noncoding RNA LINC00086 and miR-214 expression in gastric cancer.
Cancer Biomark. 24:249–255. 2019.
|
|
116
|
Yun J, Han SB, Kim HJ, Go SI, Lee WS, Bae
WK, Cho SH, Song EK, Lee OJ, Kim HK, et al: Exosomal miR-181b-5p
down- regulation in ascites serves as a potential diagnostic
biomarker for gastric cancer-associated malignant ascites. J
Gastric Cancer. 19:301–314. 2019.
|
|
117
|
Jiang X, Jiang M, Xu M, Xu J and Li Y:
Identification of diagnostic utility and molecular mechanisms of
circulating miR-551b-5p in gastric cancer. Pathol Res Pract.
215:900–904. 2019.
|
|
118
|
Li Y, Sun H, Guan J, Ji T and Wang X:
Serum microRNA-381: A potential marker for early diagnosis of
gastric cancer. Yonsei Med J. 60:720–726. 2019.
|
|
119
|
Xu YC, Liu X, Li M, Li Y, Li CY, Lu Y,
Sanches J, Wang L, Du Y, Mao LM, et al: A novel mechanism of
doxorubicin resistance and tumorigenesis mediated by
MicroRNA-501-5p-suppressed BLID. Mol Ther Nucleic Acids.
12:578–590. 2018.
|
|
120
|
Wu DM, Hong XW, Wang LL, Cui XF, Lu J,
Chen GQ and Zheng YL: MicroRNA-17 inhibition overcomes
chemoresistance and suppresses epithelial-mesenchymal transition
through a DEDD-dependent mechanism in gastric cancer. Int J Biochem
Cell Biol. 102:59–70. 2018.
|
|
121
|
Zhang H, Deng T, Liu R, Ning T, Yang H,
Liu D, Zhang Q, Lin D, Ge S, Bai M, et al: CAF secreted miR-522
suppresses ferroptosis and promotes acquired chemo-resistance in
gastric cancer. Mol Cancer. 19:432020.
|
|
122
|
Wang Z, Cai Q, Jiang Z, Liu B, Zhu Z and
Li C: Prognostic role of microRNA-21 in gastric cancer: A
meta-analysis. Med Sci Monit. 20:1668–1674. 2014.
|
|
123
|
Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY and
Yan M: microRNA-21 promotes tumor proliferation and invasion in
gastric cancer by targeting PTEN. Oncol Rep. 27:1019–1026.
2012.
|
|
124
|
Roy S, Yu Y, Padhye SB, Sarkar FH and
Majumdar AP: Difluorinated-curcumin (CDF) restores PTEN expression
in colon cancer cells by down-regulating miR-21. PLoS One.
8:e685432013.
|
|
125
|
Qiang Z, Meng L, Yi C, Yu L, Chen W and
Sha W: Curcumin regulates the miR-21/PTEN/Akt pathway and acts in
synergy with PD98059 to induce apoptosis of human gastric cancer
MGC-803 cells. J Int Med Res. 47:1288–1297. 2019.
|
|
126
|
Yan R, Li K, Yuan DW, Wang HN, Zhang Y,
Dang CX and Zhu K: Downregulation of microRNA-4295 enhances
cisplatin-induced gastric cancer cell apoptosis through the
EGFR/PI3K/Akt signaling pathway by targeting LRIG1. Int J Oncol.
53:2566–2578. 2018.
|
|
127
|
Lang C, Xu M, Zhao Z, Chen J and Zhang L:
MicroRNA-96 expression induced by low-dose cisplatin or doxorubicin
regulates chemosensitivity, cell death and proliferation in gastric
cancer SGC7901 cells by targeting FOXO1. Oncol Lett. 16:4020–4026.
2018.
|
|
128
|
Guo W, Li W, Yuan L, Mei X and Hu W:
MicroRNA-106a-3p induces apatinib resistance and activates
janus-activated kinase 2 (JAK2)/signal transducer and activator of
transcription 3 (STAT3) by targeting the SOCS system in gastric
cancer. Med Sci Monit. 25:10122–10128. 2019.
|
|
129
|
Shao L, Chen Z, Soutto M, Zhu S, Lu H,
Romero-Gallo J, Peek R, Zhang S and El-Rifai W: Helicobacter
pylori-induced miR-135b-5p promotes cisplatin resistance in
gastric cancer. FASEB J. 33:264–274. 2019.
|
|
130
|
Tang S, Fu H, Xu Q and Zhou Y: miR-20a
regulates sensitivity of colorectal cancer cells to NK cells by
targeting MICA. Biosci Rep. 39:BSR201806952019.
|
|
131
|
Shekari N, Javadian M, Ghaffari S,
Baradaran B, Darabi M and Kazemi T: DHA abolishes the detrimental
effect of docetaxel on downregulation of the MICA via decreasing
the expression level of MicroRNA-20a in gastric cancer. J
Gastrointest Cancer. 51:545–551. 2020.
|
|
132
|
Zhou X, Su J, Zhu L and Zhang G:
Helicobacter pylori modulates cisplatin sensitivity in
gastric cancer by down-regulating miR-141 expression. Helicobacter.
19:174–181. 2014.
|
|
133
|
Wang M, Qiu R, Yu S, Xu X, Li G, Gu R, Tan
C, Zhu W and Shen B: Paclitaxel-resistant gastric cancer MGC-803
cells promote epithelial-to-mesenchymal transition and
chemoresistance in paclitaxel-sensitive cells via exosomal delivery
of miR155-5p. Int J Oncol. 54:326–338. 2019.
|
|
134
|
Wei X, Gao M, Ahmed Y, Gao M, Liu W, Zhang
Y, Xie X, Zhao Q, Wang H and Gu K: MicroRNA-362-5p enhances the
cisplatin sensitivity of gastric cancer cells by targeting
suppressor of zeste 12 protein. Oncol Lett. 18:1607–1616. 2019.
|
|
135
|
Li M, Gao M, Xie X, Zhang Y, Ning J, Liu P
and Gu K: MicroRNA-200c reverses drug resistance of human gastric
cancer cells by targeting regulation of the NER-ERCC3/4 pathway.
Oncol Lett. 18:145–152. 2019.
|
|
136
|
Sui H, Lou A, Li Z and Yang J: Lidocaine
inhibits growth, migration and invasion of gastric carcinoma cells
by up-regulation of miR-145. BMC Cancer. 19:2332019.
|
|
137
|
Peng C, Huang K, Liu G, Li Y and Yu C:
miR-876-3p regulates cisplatin resistance and stem cell-like
properties of gastric cancer cells by targeting TMED3. J
Gastroenterol Hepatol. 34:1711–1719. 2019.
|
|
138
|
Kang DW, Yang ES, Noh YN, Hwang WC, Jo SY,
Suh YA, Park WS, Choi KY and Min DS: MicroRNA-320a and
microRNA-4496 attenuate Helicobacter pylori
cytotoxin-associated gene A (CagA)-induced cancer-initiating
potential and chemoresistance by targeting β-catenin and
ATP-binding cassette, subfamily G, member 2. J Pathol. 241:614–625.
2017.
|
